4.7 Article

Incretin-Based Drugs and Adverse Pancreatic Events: Almost a Decade Later and Uncertainty Remains

Journal

DIABETES CARE
Volume 38, Issue 6, Pages 951-953

Publisher

AMER DIABETES ASSOC
DOI: 10.2337/dc15-0347

Keywords

-

Ask authors/readers for more resources

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Pharmacology & Pharmacy

Use of Real-World Data to Emulate a Clinical Trial and Support Regulatory Decision Making: Assessing the Impact of Temporality, Comparator Choice, and Method of Adjustment

Devin Abrahami, Richeek Pradhan, Hui Yin, Peter Honig, Elodie Baumfeld Andre, Laurent Azoulay

Summary: External controls are primarily used in single-arm trials of rare diseases, with little investigation into their use in common diseases. This study aimed to emulate a large cardiovascular outcome trial of type 2 diabetes and found that different comparator groups, time periods, and adjustment methods can significantly impact the results. These factors must be carefully considered in the design of trial emulation studies.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Article Infectious Diseases

Epidemiology of varicella among immigrants and non-immigrants in Quebec, Canada, before and after the introduction of childhood varicella vaccination: a retrospective cohort study

Christina Greenaway, Zoe R. Greenwald, Arash Akaberi, Sunny Song, Ana Maria Passos-Castilho, Claire Nour Abou Chakra, Adam Palayew, Balquis Alabdulkarim, Robert Platt, Laurent Azoulay, Marc Brisson, Caroline Quach

Summary: Immigrants are more susceptible to varicella compared to non-immigrants before childhood varicella vaccination, but after vaccination, the incidence rates of varicella significantly decreased in both groups. Targeted vaccination for immigrants under 50 years old is recommended to reduce the risk of varicella.

LANCET INFECTIOUS DISEASES (2021)

Article Urology & Nephrology

Trends in the pharmacological treatment of benign prostatic hyperplasia in the UK from 1998 to 2016: a population-based cohort study

Henok Tadesse Ayele, Pauline Reynier, Laurent Azoulay, Robert W. Platt, Josselin Cabaussel, Serge Benayoun, Kristian B. Filion

Summary: The study reveals a significant increase in the prescription rate of BPH medications in the UK from 1998 to 2016, with the most notable growth seen in combination therapy. However, adherence to these medications among patients was found to be low.

WORLD JOURNAL OF UROLOGY (2021)

Article Cardiac & Cardiovascular Systems

Use of ACE (Angiotensin-Converting Enzyme) Inhibitors and Risk of Lung Cancer A Nationwide Nested Case-Control Study

Kasper Bruun Kristensen, Blanaid Hicks, Laurent Azoulay, Anton Pottegard

Summary: The study found that high cumulative doses of ACE inhibitors were associated with a modestly increased risk of lung cancer, while lower doses showed neutral associations. It is recommended to consider the established benefits of ACE inhibitors when interpreting these findings.

CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2021)

Article Pharmacology & Pharmacy

The reporting of observational studies of drug effectiveness and safety: recommendations to extend existing guidelines

Jacquelyn J. Cragg, Laurent Azoulay, Gary Collins, Mary A. De Vera, Mahyar Etminan, Fawziah Lalji, Andrea S. Gershon, Gordon Guyatt, Mark Harrison, Catherine Jutzeler, Rosemin Kassam, Tetyana Kendzerska, Larry Lynd, Mohammad Ali Mansournia, Mohsen Sadatsafavi, Bobo Tong, Freda M. Warner, Helen Tremlett

Summary: The use of observational data is crucial for assessing drug effectiveness and safety, and transparent, consistent, and accurate reporting of these studies is essential. Recommendations to extend existing reporting guidelines include explicit checklist items on study registration, causal diagrams, and bias assessment.

EXPERT OPINION ON DRUG SAFETY (2021)

Article Public, Environmental & Occupational Health

SGLT-2 inhibitors and the risk of hospitalization for community-acquired pneumonia: A population-based cohort study

Vanessa C. Brunetti, Pauline Reynier, Laurent Azoulay, Oriana Hoi Yun Yu, Pierre Ernst, Robert W. Platt, Kristian B. Filion

Summary: This study found that patients with type 2 diabetes using SGLT-2i had a decreased risk of hospitalization for community-acquired pneumonia compared to those using DPP-4i, but no difference when compared to GLP-1 RA.

PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2021)

Editorial Material Public, Environmental & Occupational Health

Biases in Evaluating the Safety and Effectiveness of Drugs for the Treatment of COVID-19: Designing Real-World Evidence Studies

Christel Renoux, Laurent Azoulay, Samy Suissa

Summary: The COVID-19 pandemic has sparked a surge in observational studies assessing the safety and effectiveness of various treatments, including hydroxychloroquine and renin-angiotensin-aldosterone system inhibitors. Many of these studies have been found to have issues with immortal time bias and selection bias, highlighting the importance of addressing these biases in future research.

AMERICAN JOURNAL OF EPIDEMIOLOGY (2021)

Article Public, Environmental & Occupational Health

Trends in prescribing patterns of proton pump inhibitors surrounding new guidelines

Devin Abrahami, Emily G. McDonald, Mireille Schnitzer, Laurent Azoulay

Summary: This study examined whether the latest guidelines from the National Institute for Health and Care Excellence regarding proton pump inhibitors (PPIs) had an impact on physician prescribing patterns in clinical practice. The research found that despite the guidelines, there was little meaningful change in clinical practice.

ANNALS OF EPIDEMIOLOGY (2021)

Article Pharmacology & Pharmacy

Defining Clinically Relevant Target Populations Using Real-World Data to Guide the Design of Representative Antidiabetic Drug Trials

Richeek Pradhan, Devin Abrahami, Hui Yin, Oriana H. Y. Yu, Vaishali Sahasrabudhe, Elodie Baumfeld Andre, Laurent Azoulay

Summary: This study demonstrates the importance of defining different target populations using real-world data to improve the design of future trials for antidiabetic drugs. The three target populations identified – all patients with type 2 diabetes, patients prescribed liraglutide, and patients eligible to receive liraglutide based on treatment stage – showed substantial differences in characteristics such as hemoglobin A1c, body mass index, heart failure prevalence, and chronic kidney disease. Applying the eligibility criteria of the LEADER trial to these target populations resulted in varying inclusion rates, highlighting the need for more representative trials.

CLINICAL PHARMACOLOGY & THERAPEUTICS (2021)

Article Clinical Neurology

Prescribing Trends of Antidepressants and Psychotropic Coprescription for Youths in UK Primary Care, 2000-2018

Thi Xuan Dai Cao, Lara Fernanda Costa Fraga, Emma Fergusson, Jonathan Michaud, Sophie Dell'Aniello, Hui Yin, Soham Rej, Laurent Azoulay, Christel Renoux

Summary: The study, using the Clinical Practice Research Datalink, found an increase in antidepressant prescriptions and coprescription with other psychotropic medications in children and adolescents in the UK over the past decade. Females and teenagers aged 15 to 17 had higher rates, with SSRIs being the most commonly prescribed antidepressant. The prevalence of coprescription rose from 2.6% to 6.4%, with anxiolytics and hypnotics being the most common coprescribed medications.

JOURNAL OF AFFECTIVE DISORDERS (2021)

Article Obstetrics & Gynecology

Induction of labor at 39 weeks and risk of cesarean delivery among obese women: a retrospective propensity score matched study

Alexa Eberle, Nicholas Czuzoj-Shulman, Laurent Azoulay, Haim Arie Abenhaim

Summary: The induction of labor at 39 weeks among obese women appears to decrease the risk of cesarean delivery, with a more pronounced effect seen in multiparas. Maternal outcomes were not compromised by induction, although there was an increased risk of instrumental deliveries.

JOURNAL OF PERINATAL MEDICINE (2021)

Article Oncology

Optimizing treatment sequencing of chemotherapy for patients with rectal cancer: The KIR randomized phase II trial

Aurelie Garant, Petr Kavan, Andre-Guy Martin, Laurent Azoulay, Veronique Vendrely, Caroline Lavoie, Carol-Ann Vasilevsky, Marylise Boutros, Julio Faria, Trung Nghia Nguyen, Emery Ferland, Sylvain Des Groseilliers, Alexis-Simon Cloutier, Hugo Diec, Sebastien Drolet, Carole Richard, Gerald Batist, Te Vuong

Summary: The study showed improved compliance to neoadjuvant chemotherapy. Although there was no statistical difference in tumor regression, local recurrence, and disease free survival between the two arms, a trend towards favorable outcomes was observed.

RADIOTHERAPY AND ONCOLOGY (2021)

Article Gastroenterology & Hepatology

Proton pump inhibitors and risk of colorectal cancer

Devin Abrahami, Emily Gibson McDonald, Mireille E. Schnitzer, Alan N. Barkun, Samy Suissa, Laurent Azoulay

Summary: The study found that while any use of PPIs did not increase the risk of colorectal cancer compared to H2RAs, prolonged use may be associated with a modest increased risk of this malignancy.
Article Hematology

Effectiveness and safety of direct oral anticoagulants in patients with cancer associated venous thromboembolism

Antonios Douros, Christopher Filliter, Laurent Azoulay, Vicky Tagalakis

Summary: This study demonstrates that DOACs are associated with reduced risk of recurrent VTE and major bleeding, as well as decreased all-cause mortality, compared to LMWH, in patients with cancer-related VTE.

THROMBOSIS RESEARCH (2021)

Article Public, Environmental & Occupational Health

Use of Hydrochlorothiazide and Risk of Melanoma and Nonmelanoma Skin Cancer

Julie Rouette, Hui Yin, Anton Pottegard, Krishnarajah Nirantharakumar, Laurent Azoulay

Summary: Hydrochlorothiazide use is associated with an increased risk of cSCC, with evidence of a duration- and dose-response relationship; however, there is no association with an increased risk of BCC or melanoma.

DRUG SAFETY (2021)

No Data Available